PCM
AMPE

Pinz Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Pinz Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-41
Closed -$20K – 487
2021
Q2 		$20K Buy
+41
New +$22K 0.01% 369

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

Pinz Capital Management's AMPE Position: Q3 2021 in Review

Pinz Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2021, closing a stake of 41 shares — an estimated $20K sold.

Pinz Capital Management first reported a position in AMPE in Q2 2021 and held it in 1 quarter. The position peaked at $20K in Q2 2021. 121 funds tracked by Wall St. Rank hold AMPE as of Q3 2021.

  • Pinz Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2021 after selling out during the quarter.
  • Pinz Capital Management sold 41 Ampio Pharmaceuticals Inc. shares in Q3 2021, an estimated $20K.
  • Pinz Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2021 and held it in 1 quarter.
  • Pinz Capital Management's Ampio Pharmaceuticals Inc. position peaked at $20K in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2021.

Based on Pinz Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.